Combined radiotherapy and razoxane in the treatment of chondrosarcomas and chordomas

Anticancer Research

Volumn 26, Issue 3 B, 2006, Pages 2407-2411

  Rhomberg, Walter ^a   Eiter, Helmut ^a   Böhler, Franz ^a   Dertinger, Susanne ^a  

^a Federal Academic Hospital   (Austria)

Author keywords

Chondrosarcoma; Chordoma; Radiosensitizing agents; Radiotherapy; Razoxane

Indexed keywords

RAZOXANE;

ADULT; AGED; ARTICLE; CHONDROSARCOMA; CHORDOMA; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG TOLERABILITY; FEMALE; HUMAN; LEUKOPENIA; MALE; PHOTON THERAPY; PRIORITY JOURNAL; RECURRENT DISEASE; TABLET FORMULATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BONE NEOPLASMS; CHONDROSARCOMA; CHORDOMA; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; RADIATION-SENSITIZING AGENTS; RAZOXANE;

EID: 33745583523     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Boriani S, De lure F, Bandiera S et al: Chondrosarcoma of the mobile spine: report of 22 cases. Spine 25: 804-812, 2000.
2. De Vita VT Jr, Hellman S and Rosenberg SA (eds.). Cancer. Principles & Practice of Oncology, 4th edition, JB Lippincott Comp, Philadelphia, pp. 1726-1727, 1993.
3. Lee FY, Mankin HJ, Fondren G et al: Chondrosarcoma of bone: an assessment of outcome. J Bone Joint Surg Am 81: 326-338, 1999.
4. Crockard HA, Cheeseman A, Steel T et al: A multidisciplinary team approach to skull base chondrosarcomas. J Neurosurg 95: 184-189, 2001.
5. Gadwal SR, Fanburg-Smith JC, Gannon FH and Thompson LDR: Primary chondrosarcoma of the head and neck in pediatric patients. A clinicopathologic study of 14 cases with a review of the literature. Cancer 88: 2181-2188, 2000.
6. Gripp S, Pape H and Schmitt G: Chondrosarcoma of the larynx. The role of radiotherapy revisited - a case report and review of the literature. Cancer 82: 108-115, 1998.
7. Thompson LD and Gannon FH: Chondrosarcoma of the larynx: a clinicopathologic study of 111 cases and a review of the literature. Am J Surg Path 26: 836-851, 2002.
8. Glanzmann C and Horst W: Ergebnisse der Strahlentherapie bei Chordomen. Strahlen-therapie 154: 85-88, 1978.
9. Ben M'rad S, el Hammami S, Merai S et al: Costal chondrosarcoma. 4 cases. Presse Med 28: 1355-1360, 1999.
10. Berson AM, Castro JR, Petti P, Phillips TL et al: Charged particle irradiation of chordoma and chondrosarcoma of the base of skull and cervical spine: the Lawrence Berkely Laboratory experience. Int J Radiat Oncol Biol Phys 15: 559-565, 1988.
11. Suit HD, Goitein M, Munzenrider J et al: Increased efficacy of radiation therapy by use of proton beam. Strahlenther Onkol 766: 40-44, 1990.
12. The Proton Therapy Working Party: Proton therapy for base of skull chordoma: a report for the Royal College of Radiologists. Clin Oncol (R Coll Radiol) 12: 75-79, 2000.
13. Ryall RDH, Bates T, Newton KA and Hellmann K: Combination of radiotherapy and Razoxane (ICRF 159) for chondrosarcoma. Cancer 44: 891-895, 1979.
14. Bakowski MT: ICRF 159, +/- 1,2-di (3,5-dioxopiperazinyl)-propane; NSC 129943; razoxane. Cancer Treat Rev 3: 95-107, 1976.
15. Hellmann K and Rhomberg W: Radiotherapeutic enhancement by razoxane. Cancer Treat Rev 18: 225-240, 1992.
16. Hellmann K and Murkin GE: Synergism of ICRF 159 and radiotherapy in the treatment of experimental tumors. Cancer 34: 1033-1039, 1974.
17. Rhomberg W, Hassenstein EOM and Gefeller D: Radiotherapy vs. radiotherapy and razoxane in the treatment of soft tissue sarcomas. Final results of a randomized study. Int J Radiat Oncol Biol Phys 36: 1077-1084, 1996.
18. Hellmann K: Dynamics of tumour angiogenesis: effect of razoxane-induced growth rate slowdown. Clin Expl Metastasis 20: 95-102, 2003.
19. Karakiulakis G, Missirlis E and Maragoudakis ME: Mode of action of razoxane: inhibition of basement membrane collagen-degradation by a malignant tumor enzyme. Methods Find Exp Clin Pharmacol 11: 255-261, 1989.
20. Le Serve AW and Hellmann K: Metastases and the normalization of tumor blood vessels by ICRF 159. A new type of drug action. Br Med J 1: 597-601, 1972.
21. Sharpe HBA, Field EO and Hellmann K: The mode of action of the cytostatic agent ICRF 159. Nature 226: 524-526, 1970.
22. Tanabe K, Ikegami Y, Ishida R and Andoh T: Inhibition of topoisomerase II by antitumor agents bis(2,6-dioxopiperazine) derivatives. Cancer Res 51: 4903-4908, 1991.
23. Harwood AR, Krajbich JI and Fornasier VL: Radiotherapy of chondrosarcoma of bone. Cancer 45: 2769-2777, 1980.
24. Laramore GE, Griffith JT, Boespflug M et al: Fast neutron radiotherapy for sarcomas of soft tissue, bone, and cartilage. Am J Clin Oncol 12: 320-326, 1989.
25. McNaney D, Lindberg RD, Ayala AG et al: Fifteen year radiotherapy experience with chondrosarcoma of bone. Int J Radiat Oncol Biol Phys 8: 187-190, 1982.
26. Cummings BJ, Hudson I and Bush RS: Chordoma: the results of megavoltage radiation therapy. Int J Radiat Oncol Biol Phys 9: 633-642, 1983.
27. Müller RP, Wannenmacher M, Rieck K et al: Beitrag zur Strahlentherapie der Chordome anhand eigener Fälle und im Vergleich der Literatur. Strahlentherapie 156: 92-96, 1980.
28. Catton C, O'Sullivan B, Bell R et al: Chordoma: long-term follow-up after radical photon irradiation. Radiother Oncol 41: 67-72, 1996.
29. Fuller DB and Bloom JG: Radiotherapy for chordoma. Int J Radiat Oncol Biol Phys 15: 331-339, 1988.
30. Keisch ME, Garcia DM and Shibuya RB: Retrospective long-term follow-up analysis in 21 patients with chordomas of various sites treated at a single institution. J Neurosurg 75: 374-377, 1991.
31. Bergh P, Kindblom LG, Gunterberg B et al: Prognostic factors in chordoma of the sacrum and mobile spine. A study of 39 patients. Cancer 88: 2122-2134, 2000.
32. Latz D, Gademann G, Hawighorst H et al: First results with fractionated three dimensional stereotactic radiotherapy of chordomas located at the clivus. Stahlenther Onkol 171: 348-355, 1995.
33. Weber DC, Rutz HP, Pedroni ES et al: Results of spot-scanning proton radiation therapy for chordoma and chondrosarcoma of the skull base: The Paul Scherrer Institute experience. Int J Radiat Oncol Biol Phys 63: 401-409, 2005.
34. Hofland KF, Thougaard AV, Dejligbjerg M et al: Combining etoposide and dexrazoxane synergizes with radiotherapy and improves survival in mice with central nervous system tumors. Clin Cancer Res 11: 6722-6729, 2005.